Literature DB >> 12220580

Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide.

M C Austin1, R E Whitehead, C L Edgar, J E Janosky, D A Lewis.   

Abstract

A variety of postmortem brain studies and clinical investigations have provided evidence that reduced serotonin neurotransmission is associated with suicidal behavior and depression, and several serotonergic parameters have been found to be altered in the prefrontal cortex of suicide victims. However, the integrity of the serotonin innervation of the prefrontal cortex in mood disorders has not been directly investigated. The present study used immunocytochemical methods and an antibody against the serotonin transporter to examine the relative density of serotonin axons in the dorsolateral prefrontal cortex of suicide victims with a diagnosis of major depression. The mean total length of serotonin transporter-immunoreactive axons per unit area was unchanged in layers 2 and 4 of area 46 in the depressed suicide subjects compared to controls, but was significantly (P < 0.01) decreased by 24% in layer 6 in the depressed suicide group. The total length of serotonin transporter-positive axons in layer 6 was reduced in eight of the 12 depressed suicide subjects compared to their matched control subjects. These findings reveal that depressed subjects who have committed suicide exhibit a lamina-specific reduction in a marker of serotonin axons in the dorsolateral prefrontal cortex that may reflect an alteration in cortical serotonin neurotransmission. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220580     DOI: 10.1016/s0306-4522(02)00289-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

1.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier
Journal:  Neuroscience       Date:  2017-07-13       Impact factor: 3.590

3.  Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

Authors:  Mark D Underwood; Suham A Kassir; Mihran J Bakalian; Hanga Galfalvy; J John Mann; Victoria Arango
Journal:  Int J Neuropsychopharmacol       Date:  2011-05-09       Impact factor: 5.176

4.  Serotonin transport kinetics correlated between human platelets and brain synaptosomes.

Authors:  Jeffrey L Rausch; Maria E Johnson; Junqing Li; Julian Hutcheson; Benjamin M Carr; Katina M Corley; Amanda B Gowans; Joseph Smith
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

5.  Caudothalamic dysfunction in drug-free suicidally depressed patients: an MEG study.

Authors:  Mohammad Ridwan Chattun; Siqi Zhang; Yu Chen; Qiang Wang; Nousayhah Amdanee; Shui Tian; Qing Lu; Zhijian Yao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-12-14       Impact factor: 5.270

6.  Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder.

Authors:  Michelle J Chandley; Katalin Szebeni; Attila Szebeni; Jessica Crawford; Craig A Stockmeier; Gustavo Turecki; Jose Javier Miguel-Hidalgo; Gregory A Ordway
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

7.  Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner.

Authors:  Jia Zhang; Yan Fan; Ying Li; Hobart Zhu; Liang Wang; Meng-Yang Zhu
Journal:  J Neurochem       Date:  2012-11-07       Impact factor: 5.372

Review 8.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

9.  Transcriptional expression of serotonergic regulators in laser-captured microdissected dorsal raphe neurons of subjects with major depressive disorder: sex-specific differences.

Authors:  Dharmendra B Goswami; Warren L May; Craig A Stockmeier; Mark C Austin
Journal:  J Neurochem       Date:  2009-10-29       Impact factor: 5.372

10.  Dystrophic serotonergic axons in neurodegenerative diseases.

Authors:  Efrain C Azmitia; Ralph Nixon
Journal:  Brain Res       Date:  2008-04-07       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.